[ chat, Ray ]
Thanks for the taxol link. BMY is no rare exception. The mix of politics and pharma is painful sometimes.
Don't follow MEDJ, although I have watched it, out of the corner of my eye, for a long time. I also don't follow glucose monitoring that closely, other than a bit at SPRX (they're fun from the bilirubin perspective as well) and an "every six months" peek at Cygnus. You might have fun with a hype-prone company that's into delivery and electroporation, Genetronics.
Like shooting fish in a barrel, two of our recent picks moved today, with CVAS catching second wind big-time.........
CVAS 4 7/8 + 7/8 4 7/8 3 3/4 302 +21.8%
MOGN 5 3/8 + 9/16 5 3/8 4 11/16 2998 +11.6%
MOGN looked like it was going to take off like a bullet, and then it just sorta hung in there, doggedly, toward the end.
Thanks, Ray...... like John Metcalf says.... you're making the barrel smaller.
Rick |
